| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK2292767 |
|---|
| Description | GSK2292767 is a potent and selective PI3Kδ inhibitor. GSK2292767 is currently in clinical trials for the treatment of respiratory diseases such as asthma and COPD. MW: 512.58. Purity >98% |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | GSK2292767; GSK 2292767; GSK-2292767; N-(5-(4-(5-(((2R,6S)-2,6-dimethylmorpholino)methyl)oxazol-2-yl)-1H-indazol-6-yl)-2-methoxypyridin-3-yl)methanesulfonamide |
|---|
| Gene, Accession, CAS # | CAS: 1254036-66-2 |
|---|
| Catalog # | B1660-25 |
|---|
| Price | |
|---|
| Order / More Info | GSK2292767 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|